{"name":"Ever Neuro Pharma GmbH","slug":"ever-neuro-pharma-gmbh","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPNlowTW9qbmNjQWJzWjU4b04xMF9lcmtwNTEzdTFFdkMwWnh4N2J1NWZVa21Ca1J4b29EemYtMVJXaENUaUdQTk9TWE9ka2ZrRVdfWWtJN0drZTRqY1RIRG5PMmowNW9kTDRweXhVYk05T3cwUFFwX0xJNmZqdF81NzZZLWFLX2RacVlvYmVqR0h1T1JydFZCVlk3SEJRZFF4Vzl5QUExU0V5YzJ6bUhyVG5fX0cyNEdWMVVCZGpPUUQ2UQ?oc=5","date":"2026-04-06","type":"deal","source":"Fierce Pharma","summary":"Neurocrine, eying ‘blockbuster in the making,’ strikes its largest-ever M&A deal with $2.9B Soleno buyout - Fierce Pharma","headline":"Neurocrine, eying ‘blockbuster in the making,’ strikes its largest-ever M&A deal with $2.9B Soleno buyout","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxOQ3JLVTk4RzZBTkFVdktSU2d3dkYxeUpfODRQRUdtcDdYUi12YU9LYkZiYUxfRzJkV0d3dllzSFlIbmI3ejZMV05tSll3UVBYbGM1dHhldjc5NVNkMmpEb2kyeE5xTTZpVzVZakZRWjEzQzE5bEw4Q3ktWFlONG9jeTR3MnhOVl9OY2JMdVhHMlZMbXo4NGhCZkEwSGR0UWhvN041VG5FdDFOb04tcmVhMHliUFZaMkctazNVRml2R3RJWndJaWFDOVY5Mzl0Z04ycnFySlpUQXVSbmlibF9QT0xFU0JBM1Btd2FNOUR5TW41cVo2Qi1KczlET1M?oc=5","date":"2026-03-24","type":"pipeline","source":"PR Newswire","summary":"Gilgamesh Pharma Closes Oversubscribed $60 Million Series A to Develop Next Generation Neuropsychiatric Therapies - PR Newswire","headline":"Gilgamesh Pharma Closes Oversubscribed $60 Million Series A to Develop Next Generation Neuropsychiatric Therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPcnVMNnB1LTlSTE5MRFk1WUljREZIRERUVmRZMDdHUVdnd1Z0aDJKZmFiYzRzczhzVjhkN1lGUmdYci0zT21haGdWcU13OXl3Ui1iYTl5eHRkQXZZbWllUDQzUmtjeHNoR1lwV0E0TUJXY0FDU2hCQnh6RmVDMURORTZuNmw0cWJsVTJ0dnpUbmR0T0QwRzRtWnFYQnlFcmxRcVR2VUZ0V1Q4akNjMkR0WDRKRl9mN1VmNVFHU1B3a0U1dw?oc=5","date":"2026-02-13","type":"pipeline","source":"GuruFocus","summary":"Helus Pharma (HELP) Advances Neuro Portfolio with Robust Financi - GuruFocus","headline":"Helus Pharma (HELP) Advances Neuro Portfolio with Robust Financi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxOUHpBb0lMNC0zTUxzYVFFX0t2WUF0bk94cG81aFI4dnJkT245Z3p4MnAxX3lfazZER3RBMmJCdUUyVW5pdW4yLVgwdmhzd01sSnJBcDhlUzFBaHo5ajdvRGdrS05TbDNPQk9XNzhTZ1JZcTNoNFl3ZWpWY29MRXFKdWNWMFBIb3hHQVE?oc=5","date":"2026-02-06","type":"pipeline","source":"Pharma Voice","summary":"Bayer sets the stage for a pharma comeback - Pharma Voice","headline":"Bayer sets the stage for a pharma comeback","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgJBVV95cUxPRmtxUjBjWktHOTZDSDZxWWRkeEduWTVlMEZiUjRHdkVzZGktaUgzby1RWkpwdkpRNmRrTmNCREp4eXI0c0pFMlg4Q3N1WkNmV19HM085ZThrb1J5M1AzOTJ0cjNFQXl1VmxtVDhtNnVkTm4tU1NfZ0dLZlp6OXM0b2dub005c2dnenctTEFON3hvQno0Ni1UNjB6QlFPQXRhSFVTakowVXhHbUZTLXh6RXVWX2k0c1BtaHFkRmEyOFlYT0VsaGdnNHk3bUZsazV0QlpvcS1VU0xib3pPSVZEazl0TkVkNU90MHJySE42bVEyRXcxOVRjSUJkS0lmd2V6aENwM3F6YU5YNldfdE5fVTd0cFdKZTlWSF9YWWJ1X3ZmWG04RTFZbHlBNGpXaU5Sa0E?oc=5","date":"2025-12-18","type":"pipeline","source":"globenewswire.com","summary":"Peptide Therapeutics Market Size to Surpass USD 87.21 - globenewswire.com","headline":"Peptide Therapeutics Market Size to Surpass USD 87.21","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxQeE53a2VMVzltYWZHZTl6R080cjZsMTV6b2x6c0NYSnFOUkVyM3o2c2k3Z1ZodEtZRzdrREhlWHg2cmRLNTl5aVBpSnNPVjhKdnc4Yms4eWJmYjVNa3hiRW9kdUk4ODIwYnE0OUYtdGhFY25nZ21sSkJTLVh1b2VkdTNsMEhmMGpHYS1FYXBoYUtndGo5WDVZQm91Zmp2Mnh4cGF6aWlwUEhKUlJuSzRVY3dxTjVjNERQQVU4TlpkTUNoR0ZTZlRTc2UxTFRmdXJBWmJjZw?oc=5","date":"2025-12-02","type":"pipeline","source":"EU-Startups","summary":"New approaches to ALS, Alzheimer’s and Parkinson’s receive support as Axoltis Pharma secures €18 million - EU-Startups","headline":"New approaches to ALS, Alzheimer’s and Parkinson’s receive support as Axoltis Pharma secures €18 million - EU","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNOU12dHNSZFo5OW5hUFllMnh0SXE3MnBIMm1ydlJ0Q1JocFJHU1hpbG9CZmQ3UEUwUzNkVGk1UFhmLWwyMWZnYWF6TEhuS1NRaFNUY2YyX081elo0SUxFY21YSmRDd3hxUnhQTkgwNXF6RXotdVZ6RlIxb1JmRVlpaGZzejZMZ1NwdDR3WEkxLTljVkZTak11NjAxdldXX3JUWkxLRmZkb1FvbGZsdXd2N19yWElhSmxKR1BWNHEyRQ?oc=5","date":"2025-11-03","type":"pipeline","source":"Fierce Pharma","summary":"Pharma’s corporate reputation dips among neurology patient groups, citing drug access challenges - Fierce Pharma","headline":"Pharma’s corporate reputation dips among neurology patient groups, citing drug access challenges","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE1lTWJIRGd2eWdqcGtOYk5zQ0dzR0pUc3UybGVtbjY0bkdwQ0xSODNabWw3MHBkRWFFSnViTlczdXJzR2RfOW1YVlF3VmxXYjBJVEItdy1qaTEwX0xjOGJtV2d3MHJobkFhS2VQc2xWbw?oc=5","date":"2025-09-17","type":"pipeline","source":"European Medical Journal","summary":"Pharma in Germany - European Medical Journal","headline":"Pharma in Germany","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOSVdBU2dOSUNyX3VZMmhmWlVNcFp0UjZNWlVVblB1MnlGLWdfR29PWVoyZkROTndFZW4zcV9uQThzMVlZVjg3Q3NOZ1cyUFZfZVR1cGtnczhmcEQ2M3NUUFF1WHRaLU1UZnNNbVFIbzh6TFhacFVBZ3I1VGRSenl3bQ?oc=5","date":"2025-03-31","type":"pipeline","source":"Fierce Biotech","summary":"The top 10 pharma R&D budgets for 2024 - Fierce Biotech","headline":"The top 10 pharma R&D budgets for 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOTnFrUGJCOEhwSjNYdlJ0a0JtcjkzVHJUM0ZKTjJaVHNOVnREQlN0QjZQdXFSbFRhQ25DTUphdThoN3c1dmlnNkhha3NPUUVLa2FnaGFQTnBQQkVvZmxadXBqa3NiY3RmNFdyaE10OGxwOGZoQU90dF9YSUZkQy1FNGxGVmhRdl9Wei1hQnJ5d3g0N2VLNWpqZlJ5NnI4SjFVWE85em1uNzRVVkxjYWtvWXNVUkh6S0xTYnZj?oc=5","date":"2024-08-29","type":"pipeline","source":"Pharmaceutical Technology","summary":"Who are the leading innovators in neuro-degenerative disease therapies for the pharmaceutical industry? - Pharmaceutical Technology","headline":"Who are the leading innovators in neuro-degenerative disease therapies for the pharmaceutical industry?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNQUZGSXBKaDlqU3NrVllGNGJkNVJXSnIxZG0tZU5GM2doY1dRSWVack9CSTBMLWtQRzZHdDdpOVZ1YnZWbVFNZWhKRmtIQXZpb0Y2WEFlazNwR0MwRERhdURxWmFweGg1LW1nN3h4LURyOUZDNnNDWVpyQ29YYm5jbnU5STRDM3N0a3VEM213MklPUHRTV0ZMQ3o5bjFYZ0oxR0IzSmNUaWFoczNOV3JlQkxPanlQZnNoLU93dQ?oc=5","date":"2022-07-12","type":"pipeline","source":"Business Wire","summary":"EVER Pharma Launches a Digital Training App for the D-mine® Pump - Business Wire","headline":"EVER Pharma Launches a Digital Training App for the D-mine® Pump","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTFBkUGhPTW5Od1cwRExnNUROZzVPTFhIUmd0ZW1Kd3BHMGJYYzFZRjN1V2ZnQl9wUmotVHVLdEFBN0RXUTR3T3V4S2Y3TnFmSS1VMnE3WE1vRzFuTndKNXJtNmh5QVhja3puZ0xLcFdQYm5kdw?oc=5","date":"2019-07-03","type":"pipeline","source":"NeuroNews International","summary":"EVER Pharma launches patient friendly subcutaneous pump for Parkinson’s disease - NeuroNews International","headline":"EVER Pharma launches patient friendly subcutaneous pump for Parkinson’s disease","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}